- Home
- LNKB vs ZYXI Comparison
LNKB vs ZYXI Comparison
Compare LNKB & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- ZYXI
- Stock Information
- Founded
- LNKB 2018
- ZYXI 1996
- Country
- LNKB United States
- ZYXI United States
- Employees
- LNKB N/A
- ZYXI N/A
- Industry
- LNKB
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LNKB
- ZYXI Health Care
- Exchange
- LNKB Nasdaq
- ZYXI Nasdaq
- Market Cap
- LNKB 261.4M
- ZYXI 44.8M
- IPO Year
- LNKB N/A
- ZYXI N/A
- Fundamental
- Price
- LNKB $7.02
- ZYXI $1.32
- Analyst Decision
- LNKB Strong Buy
- ZYXI Hold
- Analyst Count
- LNKB 1
- ZYXI 3
- Target Price
- LNKB $9.00
- ZYXI $3.00
- AVG Volume (30 Days)
- LNKB 109.6K
- ZYXI 75.2K
- Earning Date
- LNKB 10-27-2025
- ZYXI 10-30-2025
- Dividend Yield
- LNKB 4.29%
- ZYXI N/A
- EPS Growth
- LNKB 512.12
- ZYXI N/A
- EPS
- LNKB 1.03
- ZYXI N/A
- Revenue
- LNKB $122,594,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- LNKB $18.26
- ZYXI N/A
- Revenue Next Year
- LNKB N/A
- ZYXI $7.07
- P/E Ratio
- LNKB $6.80
- ZYXI N/A
- Revenue Growth
- LNKB 42.32
- ZYXI N/A
- 52 Week Low
- LNKB $6.09
- ZYXI $1.23
- 52 Week High
- LNKB $7.98
- ZYXI $9.33
- Technical
- Relative Strength Index (RSI)
- LNKB 48.01
- ZYXI 40.91
- Support Level
- LNKB $6.85
- ZYXI $1.30
- Resistance Level
- LNKB $7.10
- ZYXI $1.43
- Average True Range (ATR)
- LNKB 0.20
- ZYXI 0.07
- MACD
- LNKB 0.00
- ZYXI 0.00
- Stochastic Oscillator
- LNKB 32.08
- ZYXI 17.65
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.